Taysha Gene Therapies, Inc. (TSHA)
NASDAQ·Healthcare·Biotechnology
$4.91
-5.04%
Mkt Cap $1.65B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (18 analysts)
$14.00
Range $13.00 – $15.00
Implied Upside
+185.4%
Consensus $14.00 vs current $4.91
NASDAQ·Healthcare·Biotechnology
$4.91
-5.04%
Mkt Cap $1.65B
Buy
7
Hold
0
Sell
0
Price Target (18 analysts)
$14.00
Range $13.00 – $15.00
+185.4%
Consensus $14.00 vs current $4.91